The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer CachexiaErnie D. Au, Teresa A. Zimmers|Frontiers in Physiology|2017Cited by 28